[fcb5af]: / literature / by_gene / WEE1.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 35398086 10.1016/j.envres.2022.113245 2022 Molecular docking and optical sensor studies based on 2,4-diamino pyrimidine-5-carbonitriles for detection of Hg<sup>2</sup>. WEE1
2 35578798 10.1002/jcp.30777 2022 Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells. WEE1
3 31919076 10.3324/haematol.2019.231126 2021 WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. WEE1
4 33414171 10.1158/0008-5472.CAN-20-1504 2021 CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia. WEE1
5 34390915 10.1016/j.dnarep.2021.103203 2021 Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. WEE1
6 32010435 10.1177/2040620719898373 2020 WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma. WEE1
7 32314355 10.1111/bjh.16614 2020 The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma. WEE1
8 32601814 10.1007/s11864-020-00763-7 2020 Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma. WEE1
9 32892059 10.1016/j.ctrv.2020.102090 2020 Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences. WEE1
10 33374413 10.3390/ijms22010122 2020 Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies. WEE1
11 30601995 10.1093/jn/nxy224 2019 Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest. WEE1
12 30967394 10.1182/bloodadvances.2018029660 2019 MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma. WEE1
13 31064869 10.1158/1535-7163.MCT-18-0919 2019 DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas. WEE1
14 31123088 10.1158/0008-5472.CAN-18-2480 2019 Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress. WEE1
15 31341363 10.3748/wjg.v25.i26.3380 2019 Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells. WEE1
16 31590241 10.3390/cancers11101494 2019 Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells. WEE1
17 31703356 10.3390/cancers11111743 2019 WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage. WEE1
18 28025833 10.1111/bjh.14506 2018 Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation. WEE1
19 29175378 10.1016/j.leukres.2017.11.004 2018 Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine. WEE1
20 29217775 10.3324/haematol.2017.175992 2018 Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition. WEE1
21 29367434 10.1074/mcp.RA117.000539 2018 Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. WEE1
22 29489886 10.1371/journal.pone.0193098 2018 Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach. WEE1
23 29617859 10.1093/femspd/fty013 2018 Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. WEE1
24 30068368 10.1186/s13045-018-0641-1 2018 Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia. WEE1
25 27072241 10.4103/0973-1482.165861 2016 Tumour suppressive effects of WEE1 gene silencing in neuroblastomas. WEE1
26 25428911 10.18632/oncotarget.2583 2015 Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma. WEE1
27 25594541 10.1667/RR13784.1 2015 The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints. WEE1
28 25744022 10.1038/cdd.2015.13 2015 The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs. WEE1
29 26334102 10.18632/oncotarget.4830 2015 AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair. WEE1
30 26439697 10.18632/oncotarget.5954 2015 Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736. WEE1
31 22333592 10.4161/cc.11.5.19519 2012 Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. WEE1
32 18416826 10.1186/1471-2407-8-106 2008 Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. WEE1
33 12406077 10.1046/j.1365-2141.2002.03834.x 2002 Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. WEE1
34 9699647 1998 Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. WEE1
35 8833397 10.3109/10428199609052423 1996 Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint. WEE1
36 7531277 10.1007/BF00926071 1994 Changes of cell cycle-regulating genes in interferon-treated Daudi cells. WEE1